6th Annual School of Gastrointestinal Oncology® (SOGO®)

6th Annual School of Gastrointestinal Oncology® (SOGO®) is organized by Physicians' Education Resource, LLC (PER). This Online CME Course will be held on Mar 20, 2021.

Accreditation:
Physicians’ Education Resource®, LLC, assigns this online CME activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians will be able to earn the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is recommended by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Course Overview:
Returning live in 2021, the practice-changing 6th Annual School of Gastrointestinal Oncology® (SOGO®), hosted by Physicians’ Education Resource®, LLC (PER®), is a 1-day multidisciplinary educational CME conference that is transforming the presentation of rising therapies and unfolding standards of care in the management of patients with gastrointestinal (GI) cancer.

Directed by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multitrack symposium, now in its sixth year, will present you with the tools and techniques you require to customize the care for each patient with GI cancer. The online course will emphasize the general session presentations on essential concepts and debates; educational tracks examining the locoregional treatment of GI cancers and management of advanced GI cancers; and SOGO® Seminars. Choose case-based discussions on multidisciplinary, real-world management of GI cancers. This CME webinar is produced to meet your learning interests, highlighting updates on the latest clinical trial data, current and evolving treatment strategies, and case-based seminars by expert faculty, with a focus on the practical application of knowledge to the complicated care scenarios encountered in contemporary practice settings. PER® is committed to producing an interactive meeting that encourages discussion, exchange of ideas, best practices, and multidisciplinary collaboration in the clinic.

Course Objectives:
At the conclusion of this CME activity, attendees will be able to:
• Utilize molecular markers to notify diagnosis and provide treatment guidance for patients with GI cancer
• Discover a comprehensive treatment plan for patients with early-stage GI cancer in the context of multidisciplinary collaboration among radiation oncologists, surgical oncologists, and medical oncologists
• Optimize prevailing treatment strategies based on guideline updates for patients with advanced GI cancer
• Include novel treatment strategies into clinical practice to enhance the outcomes of patients with GI cancer
• Impose management strategies to proactively decrease the treatment-related adverse events experienced by patients with GI cancer

Benefits of Attending:
• Implement protocols to promote the most useful practice treatment selection for your patients with GI cancer
• Get an awareness of the clinical trials assessing current and emerging agents for GI cancer treatment that may affect your practice in the future
• Discover how the experts and your peers are managing challenging patient cases
• Ask the experts about best practices for mitigating adverse events associated to the treatment of GI cancers